PRLD insider buying & filings

PRLDPrelude Therapeutics Inc

NasdaqGS · Healthcare · $390.26M

$4.90

+4.70% · Aug 7

4 insider filings on record.
None of them an open-market buy in the last year.

Last Form 4 Oct 7 · scanned 9m ago

Price · 1Y · dailyNo open-market activity in range

▸ hover a marker for the filing · drag to zoom · 4 moves explained

AI brief · from the filings on this pagePro

The filings, the score and the setup on this page, read for you in about ten seconds — what the insiders did, and what stands against it.

Market cap

$390.26M

Float

27.6M

43% public

Short % float

Pro

Price / profit

—

not yet profitable

Price / future profit

—

Price / sales

23.3

Institutional stakes

▸ a holder crossing 5% files Schedule 13D if they intend to act on the company, 13G if they certify they will not · /A amends an earlier filing

1 filingnewest first

13GSoleus Private Equity Fund III, L.P.1.0%Jul 8

The record

newest first

DateTypeInsiderOf stakeShares @ priceValue

Oct 7TAXHuang JanePresident, CMOdirect3,355 @ $1.47$4.9K

Oct 7EXERCISEHuang JanePresident, CMOdirect9,375 sh—

Jul 8TAXHuang JanePresident, CMOdirect3,355 @ $0.7939$2.7K

Jul 8EXERCISEHuang JanePresident, CMOdirect9,375 sh—

The file stays open

▸ SEC EDGAR · FINRA · Nasdaq — public sources only · research, not advice